227 related articles for article (PubMed ID: 31579886)
1. Oncogenic Rag GTPase signaling enhances B cell activation and drives follicular lymphoma sensitive to pharmacological inhibition of mTOR.
Ortega-Molina A; Deleyto-Seldas N; Carreras J; Sanz A; Lebrero-Fernández C; Menéndez C; Vandenberg A; Fernández-Ruiz B; Marín-Arraiza L; de la Calle Arregui C; Belén Plata-Gómez A; Caleiras E; de Martino A; Martínez-Martín N; Troulé K; Piñeiro-Yáñez E; Nakamura N; Araf S; Victora GD; Okosun J; Fitzgibbon J; Efeyan A
Nat Metab; 2019 Aug; 1(8):775-789. PubMed ID: 31579886
[TBL] [Abstract][Full Text] [Related]
2. Raptor mediates the selective inhibitory effect of cardamonin on RRAGC-mutant B cell lymphoma.
Liu Y; Zhu Y; Chen H; Zhou J; Niu P; Shi D
BMC Complement Med Ther; 2023 Sep; 23(1):336. PubMed ID: 37749558
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Rag GTPase signaling in mice suppresses B cell responses and lymphomagenesis with minimal detrimental trade-offs.
Ortega-Molina A; Lebrero-Fernández C; Sanz A; Deleyto-Seldas N; Plata-Gómez AB; Menéndez C; Graña-Castro O; Caleiras E; Efeyan A
Cell Rep; 2021 Jul; 36(2):109372. PubMed ID: 34260908
[TBL] [Abstract][Full Text] [Related]
4. Recurrent Mutations in the MTOR Regulator RRAGC in Follicular Lymphoma.
Ying ZX; Jin M; Peterson LF; Bernard D; Saiya-Cork K; Yildiz M; Wang S; Kaminski MS; Chang AE; Klionsky DJ; Malek SN
Clin Cancer Res; 2016 Nov; 22(21):5383-5393. PubMed ID: 27267853
[TBL] [Abstract][Full Text] [Related]
5. Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma.
Okosun J; Wolfson RL; Wang J; Araf S; Wilkins L; Castellano BM; Escudero-Ibarz L; Al Seraihi AF; Richter J; Bernhart SH; Efeyan A; Iqbal S; Matthews J; Clear A; Guerra-Assunção JA; Bödör C; Quentmeier H; Mansbridge C; Johnson P; Davies A; Strefford JC; Packham G; Barrans S; Jack A; Du MQ; Calaminici M; Lister TA; Auer R; Montoto S; Gribben JG; Siebert R; Chelala C; Zoncu R; Sabatini DM; Fitzgibbon J
Nat Genet; 2016 Feb; 48(2):183-8. PubMed ID: 26691987
[TBL] [Abstract][Full Text] [Related]
6. mTOR Promotes Antiviral Humoral Immunity by Differentially Regulating CD4 Helper T Cell and B Cell Responses.
Ye L; Lee J; Xu L; Mohammed AU; Li W; Hale JS; Tan WG; Wu T; Davis CW; Ahmed R; Araki K
J Virol; 2017 Feb; 91(4):. PubMed ID: 27974559
[TBL] [Abstract][Full Text] [Related]
7. A proliferation-inducing ligand mediates follicular lymphoma B-cell proliferation and cyclin D1 expression through phosphatidylinositol 3-kinase-regulated mammalian target of rapamycin activation.
Gupta M; Dillon SR; Ziesmer SC; Feldman AL; Witzig TE; Ansell SM; Cerhan JR; Novak AJ
Blood; 2009 May; 113(21):5206-16. PubMed ID: 19321861
[TBL] [Abstract][Full Text] [Related]
8. Syk-dependent mTOR activation in follicular lymphoma cells.
Leseux L; Hamdi SM; Al Saati T; Capilla F; Recher C; Laurent G; Bezombes C
Blood; 2006 Dec; 108(13):4156-62. PubMed ID: 16912221
[TBL] [Abstract][Full Text] [Related]
9. Effect of PI3K- and mTOR-specific inhibitors on spontaneous B-cell follicular lymphomas in PTEN/LKB1-deficient mice.
García-Martínez JM; Wullschleger S; Preston G; Guichard S; Fleming S; Alessi DR; Duce SL
Br J Cancer; 2011 Mar; 104(7):1116-25. PubMed ID: 21407213
[TBL] [Abstract][Full Text] [Related]
10. Amino acids activate mammalian target of rapamycin (mTOR) complex 1 without changing Rag GTPase guanyl nucleotide charging.
Oshiro N; Rapley J; Avruch J
J Biol Chem; 2014 Jan; 289(5):2658-74. PubMed ID: 24337580
[TBL] [Abstract][Full Text] [Related]
11. De novo missense variants in RRAGC lead to a fatal mTORopathy of early childhood.
Reijnders MRF; Seibt A; Brugger M; Lamers IJC; Ott T; Klaas O; Horváth J; Rose AMS; Craghill IM; Brunet T; Graf E; Mayerhanser K; Hellebrekers D; Pauck D; Neuen-Jacob E; Rodenburg RJT; Wieczorek D; Klee D; Mayatepek E; Driessen G; Bindermann R; Averdunk L; Lohmeier K; Sinnema M; Stegmann APA; Roepman R; Poulter JA; Distelmaier F
Genet Med; 2023 Jul; 25(7):100838. PubMed ID: 37057673
[TBL] [Abstract][Full Text] [Related]
12. Proton-assisted amino acid transporter PAT1 complexes with Rag GTPases and activates TORC1 on late endosomal and lysosomal membranes.
Ögmundsdóttir MH; Heublein S; Kazi S; Reynolds B; Visvalingam SM; Shaw MK; Goberdhan DC
PLoS One; 2012; 7(5):e36616. PubMed ID: 22574197
[TBL] [Abstract][Full Text] [Related]
13. Coordination of the leucine-sensing Rag GTPase cycle by leucyl-tRNA synthetase in the mTORC1 signaling pathway.
Lee M; Kim JH; Yoon I; Lee C; Fallahi Sichani M; Kang JS; Kang J; Guo M; Lee KY; Han G; Kim S; Han JM
Proc Natl Acad Sci U S A; 2018 Jun; 115(23):E5279-E5288. PubMed ID: 29784813
[TBL] [Abstract][Full Text] [Related]
14. Genetic and epigenetic inactivation of
Oricchio E; Katanayeva N; Donaldson MC; Sungalee S; Pasion JP; Béguelin W; Battistello E; Sanghvi VR; Jiang M; Jiang Y; Teater M; Parmigiani A; Budanov AV; Chan FC; Shah SP; Kridel R; Melnick AM; Ciriello G; Wendel HG
Sci Transl Med; 2017 Jun; 9(396):. PubMed ID: 28659443
[TBL] [Abstract][Full Text] [Related]
15. Amino acid regulation of TOR complex 1.
Avruch J; Long X; Ortiz-Vega S; Rapley J; Papageorgiou A; Dai N
Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E592-602. PubMed ID: 18765678
[TBL] [Abstract][Full Text] [Related]
16. Distinct amino acid-sensing mTOR pathways regulate skeletal myogenesis.
Yoon MS; Chen J
Mol Biol Cell; 2013 Dec; 24(23):3754-63. PubMed ID: 24068326
[TBL] [Abstract][Full Text] [Related]
17. Regulation of mTORC1 by the Rag GTPases is necessary for neonatal autophagy and survival.
Efeyan A; Zoncu R; Chang S; Gumper I; Snitkin H; Wolfson RL; Kirak O; Sabatini DD; Sabatini DM
Nature; 2013 Jan; 493(7434):679-83. PubMed ID: 23263183
[TBL] [Abstract][Full Text] [Related]
18. Concurrent inhibition of PI3K and mTORC1/mTORC2 overcomes resistance to rapamycin induced apoptosis by down-regulation of Mcl-1 in mantle cell lymphoma.
Müller A; Zang C; Chumduri C; Dörken B; Daniel PT; Scholz CW
Int J Cancer; 2013 Oct; 133(8):1813-24. PubMed ID: 23580240
[TBL] [Abstract][Full Text] [Related]
19. RhoA modulates signaling through the mechanistic target of rapamycin complex 1 (mTORC1) in mammalian cells.
Gordon BS; Kazi AA; Coleman CS; Dennis MD; Chau V; Jefferson LS; Kimball SR
Cell Signal; 2014 Mar; 26(3):461-7. PubMed ID: 24316235
[TBL] [Abstract][Full Text] [Related]
20. The E-Id protein axis modulates the activities of the PI3K-AKT-mTORC1-Hif1a and c-myc/p19Arf pathways to suppress innate variant TFH cell development, thymocyte expansion, and lymphomagenesis.
Miyazaki M; Miyazaki K; Chen S; Chandra V; Wagatsuma K; Agata Y; Rodewald HR; Saito R; Chang AN; Varki N; Kawamoto H; Murre C
Genes Dev; 2015 Feb; 29(4):409-25. PubMed ID: 25691468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
